NASDAQ · LVOX
Technology · Software - Infrastructure
$3.73
Up+$0.03 (+0.81%)
Updated Aug 13, 2026, 3:44 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
LVOX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning LVOX.
LVOX research
Company profile and research snapshot.
LiveVox, Inc. develops and provides cloud contact center software for businesses. Its products include Four Clouds, an outbound voice solution that enables to manage regulatory requirements with the option of three manual and one automated outbound dialing system; bundles, including two-way messaging, outbound campaigns and compliance, speech analytics, inbound contact center, and cloud interactive voice response (IVR) solutions; inbound voice solutions, which comprise automatic call distributor, IVR, and wallboards; and blended omnichannel solutions, such as voice, email, SMS, virtual agents, and webchat. The company also offers CRM, which leverages unified customer profiles to create, facilitate, and manages digital engagement; Workforce Optimization, that helps contact centers to measure and manage agent workforce; and SpeechIQ, an AI-driven speech analytics solution to promote compliance, productivity, and quality in contact centers. It serves financial services, teleservices, healthcare, telecom, customer care, BPO, and collection industries. The company has a strategic partnership with Telarus. LiveVox, Inc. was formerly known as Tools For Health, Inc. and changed its name to LiveVox, Inc. in June 2006. The company was incorporated in 1998 and is based in San Francisco, California. LiveVox, Inc. has additional locations in Atlanta, Georgia; Bengaluru, India; Denver, Colorado; Medellin, Colombia; New York, New York; St. Louis, Missouri; and Columbus, Ohio.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2023 | Northland Capital Markets | Market Perform | — |
| Oct 4, 2023 | Stifel | Hold | — |
| Aug 10, 2023 | Benchmark | Buy | — |
| May 16, 2023 | Credit Suisse | Neutral | — |
| May 10, 2023 | Cantor Fitzgerald | Overweight | — |
No generated briefing is available yet.
Zacks Investment Research · Oct 24, 2023
Alphabet Inc. (GOOG) delivered earnings and revenue surprises of 6.90% and 1.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Benzinga · Oct 5, 2023
Oppenheimer analyst Timothy Horan reiterated the Outperform rating on NICE Ltd (NASDAQ: NICE), with a price target of $225, down from $250. NICE will acquire LiveVox Holdings, Inc. (NASDAQ: LVOX) for $3.74/share in an all-cash deal, implying a firm value of $387 million, or 2.7x annualized 2Q23 revenue. LVOX has taken significant cost-cutting measures with EBITDA margins +2,000bps year/year in 2Q23, which NICE should be able to further accelerate, the analyst adds. Horan estimates LVOX to contribute $100 million to cloud revenue in 2024. NICE's Customer Engagement business is driven by intensifying corporate compliance and risk-management efforts and by corporate efforts to increase ...Full story available on Benzinga.com
Benzinga · Oct 4, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares surged 39.7% to $6.72. LiveVox Holdings, Inc. (NASDAQ: LVOX) climbed 8.1% to $3.61 after NICE announced it will acquire the company. FREYR Battery (NYSE: FREY) gained 7.5% to $4.9250. FREYR issued an update this ...
Zacks Investment Research · Aug 8, 2023
LiveVox Holdings, Inc. (LVOX) delivered earnings and revenue surprises of 0% and 1.76%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LVOX.
No results
No recent SID articles mention LVOX.
